The Democratic Republic Of Congo's Weapon Against Ebola? Entrepreneurship
Congo's new president prioritizes digitization and entrepreneurship to tackle Ebola and other problems. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 28, 2019 Category: Pharmaceuticals Authors: Amy Guttman, Contributor Source Type: news

Mole-Mapping App Miiskin Uses AI To Help Adults Detect Warning Signs Of Melanoma
Miiskin's technology uses AI to digitally map out the skin to make it easier for its users to detect new moles, freckles and other marks (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 28, 2019 Category: Pharmaceuticals Authors: Lee Bell, Contributor Source Type: news

On-Demand Fitness App Fiit Launches Fiit Club, Streamed HIIT Classes With Live Leaderboards
Fitness nuts can log in and do a live class from the comfort of their own home (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 28, 2019 Category: Pharmaceuticals Authors: Lee Bell, Contributor Source Type: news

H ôpital Albert Schweitzer Haiti's new CEO on a mission to save hospital
Many factors are threatening the struggling Haitian health system with Pittsburgh ties. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 28, 2019 Category: Pharmaceuticals Authors: Paul J. Gough Source Type: news

Enhancing the Paragraph IV Patent Certifications List database
FDA looks to improve transparency and predictability for generic drug applicants (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - June 28, 2019 Category: Pharmaceuticals Source Type: news

European regulators won't back Amgen/UCB drug
Amgen and Belgian partners at UCB announced that the EMA has adopted a negative opinion on Evenity, for the treatment of osteoporosis in men and in postmenopausal women at increased risk of fracture. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - June 28, 2019 Category: Pharmaceuticals Source Type: news

2019 EY Entrepreneur Of The Year winners unveiled
For over 30 years, Ernst& Young LLP's EY Entrepreneur Of The Year awards have recognized the forward-thinking business people who exemplify the best of American industry. It's quite a feather in the cap of a CEO. For the 2019 edition of EOY, 10 Central Texas entrepreneurs — some bolstered by computer chips, others by chocolate chips — elevated themselves through their clarity of purpose, innovative thinking and tenacious drive. The winners were announced June 27 before a packed house at the… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 28, 2019 Category: Pharmaceuticals Authors: Colin Pope Source Type: news

Spike In Autism May Be Linked To Preservative In Processed Foods, Study Suggests
While prior studies have suggested the role of genetic factors and environmental influence in ASD, this is the first study to note a molecular link from elevated levels of PPA, overproduction of glial cells, disruption of neural connections and autism spectrum disorder. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 28, 2019 Category: Pharmaceuticals Authors: Robert Glatter, MD, Contributor Source Type: news

Meet XS Supply, a 2019 Fast 50 honoree
XS Supply LLC Location: Largo Top executive: Jon Bird, CEO How would you describe what your company does to a friend or family member who may not know? XS Supply helps hospitals and surgery centers throughout the U.S. in two ways. First, we purchase overstock or unwanted surgery supplies due to over ordering or surgeon preference changes before the inventory expires. This helps facilities avoid or minimize loss. Second, we resell the overstock inventory we purchase from other facilities at a discounted… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 28, 2019 Category: Pharmaceuticals Authors: Chris Erickson Source Type: news

Digital Health Company Livongo Files For An IPO
Digital health startups have raised billions in venture funding but produced zero IPOs since 2016; the dry spell is ending. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 28, 2019 Category: Pharmaceuticals Authors: Zina Moukheiber, Contributor Source Type: news

UnitedHealth Group Shuffling C-Suite Executives
The move will mean new leadership at both UnitedHealthcare and Optum, UnitedHealth ’s fast-growing healthcare services because Nelson will be replaced by Dirk McMahon, the current president and chief operating officer at Optum. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 28, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

Florida Picks Harm Reduction Over Politics With New Needle Exchange Law
State lawmakers approved a program for safe syringe exchanges, giving county leaders the choice to use life-saving tools. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 28, 2019 Category: Pharmaceuticals Authors: Janet Burns, Contributor Source Type: news

Florida Picks Harm Reduction Over Politics With Needle Exchange Law
State lawmakers approved a program for safe syringe exchanges, giving county leaders the choice to use life-saving tools. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 28, 2019 Category: Pharmaceuticals Authors: Janet Burns, Contributor Source Type: news

Parent of not-for-profit vision benefits co. to buy Texas-based Visionworks
VSP Global — a physician-led company based in Rancho Cordova, California — has agreed to buy San Antonio-based Visionworks, one of the nation’s largest retail optical chains. Terms of the definitive agreement were not disclosed. The transaction is expected to close after regulatory approvals are granted , according to a press release. There are no plans to move Visionworks' employees or headquarters from San Antonio, a VSP official said. Visionworks operates more than 700 optical stores in… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 28, 2019 Category: Pharmaceuticals Authors: W. Scott Bailey Source Type: news

Kaiser opens imaging suite at Mapunapuna Medical Office
Kaiser Permanente held a blessing ceremony Tuesday for its new CT and MRI imaging suite at its Mapunapuna Medical Office, the first outpatient medical office in the system to house specialty imaging equipment. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 28, 2019 Category: Pharmaceuticals Authors: Kelsey Kukaua Source Type: news

Powerful opioid lollipop was illegally marketed, ex-pharma rep says
Fearing patients would die, a former pharmaceutical rep went undercover for FDA investigators to stop the illegal "off-label" promotion of an opioid lollipop (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 28, 2019 Category: Consumer Health News Source Type: news

2 Nights, 10 Health Takeaways From The Democratic Debates
Americans like Medicare for All (MFA) in theory, but not in practice. Making the Democratic debate on MFA a waste of time for everyone. But that didn't stop the 2020 presidential candidates from discussing insurance, pharma& changes to the health system - particularly as it pertains to MFA. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 28, 2019 Category: Pharmaceuticals Authors: Nicole Fisher, Contributor Source Type: news

Lannett Enters Into Distribution Agreement For Dantrolene Capsules, Commences Product Launch
PHILADELPHIA, June 28, 2019 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into a three-year agreement with Elite Pharmaceuticals to be the exclusive U.S. distributor of a Dantrolene Caps... Biopharmaceuticals, Generics, Distribution, Product Launch Lannett, Elite Pharmaceuticals, Dantrolene, Dantrium (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 28, 2019 Category: Pharmaceuticals Source Type: news

BioAtla Appoints Eric Sievers, M.D., As Chief Medical Officer
Experienced leader of oncology clinical trial approvals to head BioAtla's clinical development programs SAN DIEGO, June 28, 2019 -- (Healthcare Sales & Marketing Network) -- BioAtla, LLC, a global biotechnology company focused on the development of Con... Biopharmaceuticals, Oncology, Personnel BioAtla , Conditionally Active Biologic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 28, 2019 Category: Pharmaceuticals Source Type: news

Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group
ARTARMON, Australia, June 28, 2019 -- (Healthcare Sales & Marketing Network) -- Saluda Medical Pty Limited ("Saluda Medical") today announced that it has secured $75 million in equity financing from Boston Scientific Corporation (NYSE: BSX) and ... Devices, Neurology, Venture Capital Saluda Medical, Boston Scientific, Evoke , Spinal Cord Stimulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 28, 2019 Category: Pharmaceuticals Source Type: news

Florida's 'shared savings' plan could get off to slow start
While Gov. Ron DeSantis and House leaders are enthusiastic about "shared savings" health-care programs, state economists are not so sure the programs will have a big immediate impact.   The programs are designed to give insurance policyholders an incentive to shop for cheaper health-care services and are allowed under a bill (HB 1113) signed into law last week by DeSantis. Under the law, insurance companies and HMOs will be able to provide incentives for policyholders to use “ shoppable services.”… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 28, 2019 Category: Pharmaceuticals Authors: Christine Sexton Source Type: news

Women Who Tech Launches Health Innovation Challenge
Non-profit Women Who Tech has opened applications for the European leg of its global startup Challenge, with the winner set to receive a $50,000 innovation grant. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 28, 2019 Category: Pharmaceuticals Authors: Nicholas Fearn, Contributor Source Type: news

Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
THOUSAND OAKS, Calif. and BRUSSELS, June 27, 2019 -- (Healthcare Sales & Marketing Network) -- Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels: UCB) today announced that the companies have been informed the Committee for Medicinal Products for Human Use (C... Biopharmaceuticals, Regulatory Amgen, UCB , EVENITY, romosozumab, osteoporosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 28, 2019 Category: Pharmaceuticals Source Type: news

Vision care insurance provider VSP buys Visionworks retail chain
VSP Global vision care company is buying Visionworks, one of the nation ’s largest retail optical chains. Terms of the definitive agreement were not disclosed. The transaction is expected to close after regulatory approvals are granted. “This transaction is highly complementary to our business and marks a significant leap forward in continuing to fulfill our visio n to provide access to affordable, high-quality eye care and eyewear to more people,” VSP CEO Michael Guyette said in a news release… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 28, 2019 Category: Pharmaceuticals Authors: Emily Hamann Source Type: news

Back-to-back regulatory approvals send Durham drugmaker's stock soaring
A rapid series of regulatory approvals has a Durham-based drugmaker's stock soaring – recovering from a sharp drop last year. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 28, 2019 Category: Pharmaceuticals Authors: Seth Thomas Gulledge Source Type: news

Optum exec will become new UnitedHealthcare CEO
UnitedHealth Group Inc. on Friday announced a new CEO for UnitedHealthcare, picking the No. 2 executive at its fast-growing Optum subsidiary to lead its core health-insurance business. The Minnetonka-based insurance giant said that Dirk McMahon, currently president and chief operating officer of Optum, will move into the CEO role at UnitedHealthcare. He replaces Steve Nelson, who is retiring from the company. Daniel Schumacher, currently president and COO at UnitedHealthcare, w ill move into McMahon's… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 28, 2019 Category: Pharmaceuticals Authors: Mark Reilly Source Type: news

Second executive since Jacobs' ouster leaving Acadia
Ron Fincher has been replaced by a former Universal Health Services vice president — the same company where Acadia's new CEO was an executive. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 28, 2019 Category: Pharmaceuticals Authors: Joel Stinnett Source Type: news

Myocardial Perfusion PET Predicts Cardiac Death in Diabetes
FRIDAY, June 28, 2019 -- Myocardial perfusion positron emission tomography (PET) imaging can improve risk prediction of cardiac death for patients with diabetes, according to a study published online June 27 in Radiology: Cardiothoracic... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 28, 2019 Category: Pharmaceuticals Source Type: news

Morning Preference Has Protective Effect on Breast Cancer Risk
FRIDAY, June 28, 2019 -- Morning preference seems to have a protective effect on breast cancer risk, according to a study published online June 26 in The BMJ. Rebecca C. Richmond, Ph.D., from the University of Bristol in the United Kingdom, and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 28, 2019 Category: Pharmaceuticals Source Type: news

Soliris Approved to Treat Neuromyelitis Optica Spectrum Disorder
FRIDAY, June 28, 2019 -- The U.S. Food and Drug Administration has approved Soliris (eculizumab) injection as the first treatment for neuromyelitis optica spectrum disorder (NMOSD), the agency announced Thursday. Soliris is indicated for intravenous... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 28, 2019 Category: Pharmaceuticals Source Type: news

Review: HPV Vaccination Program Has Considerable Impact
FRIDAY, June 28, 2019 -- The human papillomavirus (HPV) vaccination program has had a considerable impact, according to a study published online June 26 in The Lancet. M élanie Drolet, Ph.D., from the Université Laval in Québec, Canada, and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 28, 2019 Category: Pharmaceuticals Source Type: news

Family History of Dementia Tied to Early Memory Deficits
FRIDAY, June 28, 2019 -- A first-degree family history of dementia is associated with memory deficits decades before the typical onset of Alzheimer disease, according to a study published online June 18 in eLife. Joshua S. Talboom, Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 28, 2019 Category: Pharmaceuticals Source Type: news

Infections Tied to Subsequent Risk for Acute Ischemic Stroke
FRIDAY, June 28, 2019 -- Different infection types, especially urinary tract infection (UTI), are associated with subsequent acute ischemic stroke, according to a study published online June 27 in Stroke. Solly Sebastian, from the Icahn School of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 28, 2019 Category: Pharmaceuticals Source Type: news

Social Media Use Tied to Esteem, Cosmetic Surgery Acceptance
FRIDAY, June 28, 2019 -- Users of some social media platforms and photo editing have lower self-esteem and increased acceptance of cosmetic surgery, according to a study published online June 27 in JAMA Facial Plastic Surgery. Jonlin Chen, from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 28, 2019 Category: Pharmaceuticals Source Type: news

Use of 3-D Mammography Rapidly Expanded 2015 to 2017
FRIDAY, June 28, 2019 -- Adoption of 3-D mammography expanded rapidly in the United States in just a few years, particularly in areas with greater socioeconomic resources, according to a research letter published online June 24 in JAMA Internal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 28, 2019 Category: Pharmaceuticals Source Type: news

Increase Seen in Cryptosporidiosis Outbreaks From 2007 to 2019
FRIDAY, June 28, 2019 -- From 2009 to 2017, there was an increase in the annual number of reported cryptosporidiosis outbreaks in the United States, according to a study published online June 27 in Morbidity and Mortality Weekly Report. Radhika... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 28, 2019 Category: Pharmaceuticals Source Type: news

Functional Decline Seen in Many Older Adults Initiating Dialysis
FRIDAY, June 28, 2019 -- For older adults initiating dialysis, many experience a decline in functional status after six months, and the prevalence of high caregiver burden increases, according to a study published online June 27 in the Clinical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 28, 2019 Category: Pharmaceuticals Source Type: news

CHMP recommends EU approval of Roche ’s Tecentriq in combination with Abraxane as an initial treatment for people with PD-L1-positive, metastatic triple-negative breast cancer
Roche today announced that the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Tecentriq® (atezolizumab) plus chemotherapy (Abraxane®; nab-paclitaxel) for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) whose t umours have PD-L1 expression (≥ 1%) and who have not received prior chemotherapy for metastatic disease. (Source: Roche Investor Update)
Source: Roche Investor Update - June 28, 2019 Category: Pharmaceuticals Source Type: news

CHMP recommends EU approval of Roche ’s Tecentriq in combination with Abraxane as an initial treatment for people with PD-L1-positive, metastatic triple-negative breast cancer
Roche today announced that the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Tecentriq® (atezolizumab) plus chemotherapy (Abraxane®; nab-paclitaxel) for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) whose t umours have PD-L1 expression (≥ 1%) and who have not received prior chemotherapy for metastatic disease. (Source: Roche Media News)
Source: Roche Media News - June 28, 2019 Category: Pharmaceuticals Source Type: news

Artificial DNA can control release of active ingredients from drugs
A drug with three active ingredients that are released in sequence at specific times: Thanks to the work of a team at the Technical University of Munich (TUM), what was once a pharmacologist's dream is now much closer to reality. With a combination of hydrogels and artificial DNA, nanoparticles can be released in sequence under conditions similar to those in the human body. (Source: World Pharma News)
Source: World Pharma News - June 28, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Pharma-owned plasma center set for major expansion in metro Phoenix
Plans call for opening four centers this year that would employ 140 people in the region. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 28, 2019 Category: Biotechnology Authors: Angela Gonzales Source Type: news

Amgen and UCB Provide Regulatory Update on Status of EVENITY ™ (romosozumab) in the EU
THOUSAND OAKS, Calif. and BRUSSELS, June 27, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels: UCB) today announced that the companies have been informed the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion on the Marketing Authorization Application for EVENITYTM (romosozumab) for the treatment of severe osteoporosis. The companies intend to submit a written notice for a re-examination by the CHMP. "After a fracture, postmenopausal women with osteoporosis are five times more likely to fracture in the subsequent year,1 a...
Source: Amgen News Release - June 28, 2019 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Pharma in review: trending stories 6/28/19
Most popular Pharma Manufacturing stories from the past seven days. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - June 28, 2019 Category: Pharmaceuticals Source Type: news

Local health providers build for better mental health
A severe shortage of inpatient beds, spurred by reimbursement shortfalls, puts pressure on mental healthcare providers throughout Santa Clara County. Here ’s how local health providers are adapting to a growing need. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 28, 2019 Category: Pharmaceuticals Authors: Chris Rauber Source Type: news

Lab Instrumentation Goes Portable, and It Is a $1.5 Billion Market
Strategic Directions International releases new report on Portable Lab Instrumentation Market.(PRWeb June 28, 2019)Read the full story at https://www.prweb.com/releases/lab_instrumentation_goes_portable_and_it_is_a_1_5_billion_market/prweb16412494.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 28, 2019 Category: Pharmaceuticals Source Type: news

Ex-FDA boss joins Pfizer 83 days after leaving regulator
Move by Scott Gottlieb adds to sense of ‘revolving door’ between government and industry (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 28, 2019 Category: Pharmaceuticals Source Type: news

Deal to acquire optical retailer marks VSP's largest network investment to date
VSP Global, the Rancho Cordova-based vision care company, is buying San Antonio-based Visionworks, one of the nation ’s largest retail optical chains. Terms of the definitive agreement were not disclosed. The transaction is expected to close after regulatory approvals are granted. “This transaction is highly complementary to our business and marks a significant leap forward in continuing to fulfill our visio n to provide access to affordable, high-quality eye care and eyewear to more people,”… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 27, 2019 Category: Pharmaceuticals Authors: Emily Hamann Source Type: news

Minnesota Cup winner MicroOptx raises $13.8 million
Editor's note:  This story comes from our online sister publication, Minne Inno, which focuses on the Twin Cities startup scene. Want more stories about tech and innovation in the Minneapolis-St. Paul area? Subscribe to the Beat by Minne Inno, a free daily email newsletter that breaks down everything you need to know about what's new in business the Twin Cities. MicroOptx Inc., a medical-device company that won the Minnesota Cup’s grand prize in 2017, has raised $13.8 million in a planned… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 27, 2019 Category: Pharmaceuticals Authors: Maddy Kennedy Source Type: news

Patents hint at breakthroughs for local med tech companies
SVBJ's List this week offers a look at the region's medical technology companies, ranked by 2018 revenue. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 27, 2019 Category: Pharmaceuticals Authors: Rosellen "Rosie" Downey Source Type: news

Hospital CEOs tell why grabbing bankrupt Verity's assets made sense
Integration of facilities and staff from Verity Health into Santa Clara County's hospital system and El Camino Hospital is going well, CEOs say. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 27, 2019 Category: Pharmaceuticals Authors: Jody Meacham Source Type: news